1. Overview of Filing and Purpose
Genesco Inc. has filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended January 31, 2026. This amendment primarily serves to provide the information required by Part III of Form 10-K, which was not included in the original filing as the company will not file a definitive proxy statement within 120 days of fiscal year-end. No financial statements are included in this amendment, and no certifications pursuant to Section 906 of the Sarbanes-Oxley Act are provided. Investors should note that except for Part III and updated share information, no other changes have been made, and the original filing continues to speak as of its date. Subsequent events are not updated in this amendment.
2. Shareholder Information and Market Value
- Market Value: The aggregate market value of voting and non-voting common equity held by non-affiliates as of the last business day of the registrant’s most recently completed second fiscal quarter is \$255,000,000, calculated at a per share price of \$23.64.
- Shares Outstanding: As of May 18, 2026, there were 11,103,175 shares of Genesco’s common stock outstanding.
- Trading Symbol: GCO on the New York Stock Exchange.
- Other Registered Securities: Employee Subordinated Convertible Preferred Stock.
3. Company Status and Compliance
- Genesco is not a shell company.
- It is not an emerging growth company.
- The company is not a smaller reporting company.
- Genesco is not a voluntary filer; it is required to file under Section 13 or 15(d).
- All required reports and Interactive Data Files have been filed timely.
- Attestation on internal control over financial reporting (Section 404(b) Sarbanes-Oxley) has been provided.
- No correction of previously issued financial statements or restatements requiring recovery analysis of incentive compensation.
4. Executive Compensation: Fiscal 2026 Details
Pay-for-Performance Philosophy: Genesco’s executive compensation is directly aligned with company financial performance. The company operates a robust and ongoing shareholder engagement program, with 88% of shareholders voting in favor of executive compensation at the 2025 annual meeting. No changes were made to the compensation program as a result of this vote, but shareholder input remains integral to the compensation committee’s evaluations.
A. Compensation Structure and Changes
-
Executive Officers Named:
- Mimi E. Vaughn – Chair of the Board, President, CEO, and Interim CFO
- Cassandra E. Harris – Former SVP Finance and CFO
-
Base Salary Increases for Fiscal 2026:
- Mimi E. Vaughn: \$600,000
- Other executive officers (example): \$450,000
- Another named executive: \$635,000
- Annual Incentive (EVA Plan): All executive officers participate in the EVA Plan, rewarding increases in earnings above the company’s cost of capital. The plan aligns pay and performance, with targets based on long-term average EVA growth compared to peers. Bonuses are calculated based on business unit EVA improvement, with specific intervals for performance at or above/below target.
-
Restricted Stock and PSUs:
- The vesting schedule for restricted shares has been shortened from four to three years starting in Fiscal 2024, aligning with market practice.
- PSUs granted in July 2025 are based on cumulative adjusted operating income over three years (ending January 29, 2028).
- Grant date fair values for restricted stock and PSUs are specified for each executive officer, with the value tied to the company’s share price.
Compensation Committee Process: The committee uses market data, independent consultants, and CEO input to determine executive pay. It met 11 times in Fiscal 2026.
5. Board and Committees: Governance and Financial Oversight
-
Audit Committee:
- Consists of three independent directors (Mary E. Meixelsperger, Matthew M. Bilunas, Gregory A. Sandfort).
- Met 15 times in Fiscal 2026.
- Oversees financial statements, internal controls, ethics, risk management, and auditor independence.
- All members qualify as “audit committee financial experts.”
-
Compensation Committee:
- Consists of three independent directors (John F. Lambros, Joanna Barsh, Gregory A. Sandfort).
- Responsible for executive compensation, employee benefit plans, and equity incentive plan administration.
- Met 11 times in Fiscal 2026.
6. Legal Proceedings and Compliance
- No legal proceedings involving directors required to be disclosed under Item 401(f) of Regulation S-K.
- Full compliance with Section 16(a) of the Exchange Act and insider trading policies and procedures.
7. Shareholder Engagement and Potential Price Sensitivity
-
Price-Sensitive Factors:
- Updated share count and market value may affect valuation metrics.
- Executive compensation aligned with performance and market practice, including shortened restricted stock vesting, could impact retention and motivation of leadership.
- Robust compliance and governance structure, with no financial restatements or legal issues, may be viewed positively by the market.
- No Financial Restatement or Error Correction: This is an important signal to the market that the company’s accounting and reporting practices are stable and trustworthy.
8. Documents Incorporated by Reference
None.
9. Conclusion: Investor Implications
Genesco Inc.’s amendment to its 10-K is predominantly administrative, providing Part III information that was omitted from the original filing. The most price-sensitive elements are the updated share count and market value, changes to executive compensation structure (particularly the shortened vesting period for restricted shares and the performance targets for PSUs), and continued strong governance and compliance. No financial restatements, legal issues, or proxy-related changes are present. These factors collectively indicate stability and alignment of management incentives with shareholder interests, which may positively influence investor sentiment.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review Genesco Inc.’s filings and consult with their financial advisors before making any investment decisions. The information presented is based on the company’s SEC filings and may not reflect subsequent events or filings.
